Ivabradine in Combination With Metoprolol Succinate in the Treatment of Inappropriate Sinus Tachycardia

Ptaszyński, Paweł; Kaczmarek, Krzysztof; Ruta, Jan; Klingenheben, Thomas; Cygankiewicz, Iwona; Wranicz, Jerzy Krzysztof

doi:10.1177/1074248413478172

Cited by 46 publications

(36 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The drug has no other hemodynamic effects aside from lowering the heart rate. As such, it has been investigated for use to reduce the sinus rate and improve symptoms related to IST (85)(86)(87)(88)(89)(90)(91)(92)(93).…”

Section: Ongoing Management: Recommendationsmentioning

confidence: 99%

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary

Page¹,

Joglar²,

Caldwell³

et al. 2016

Journal of the American College of Cardiology

View full text Add to dashboard Cite

Section: Ongoing Management: Recommendationsmentioning

confidence: 99%

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary

Page¹,

Joglar²,

Caldwell³

et al. 2016

Journal of the American College of Cardiology

View full text Add to dashboard Cite

“…Furthermore, ivabradine can provide benefits when added to beta-blocker therapy. 64 Ivabradine is not yet available in all countries, although it might appear in the next 2–3 years.…”

Section: Section 2: Inappropriate Sinus Tachycardia Definitionmentioning

confidence: 99%

2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope

et al. 2015

View full text Add to dashboard Cite

“…43,44 Ivabradine is not available in all countries but is likely to become increasingly so in the next 2-3 years. …”

Section: Treatmentmentioning

confidence: 99%

Management of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia and Vasovagal Syncope

Raj

Sheldon

2016

Arrhythmia &Amp; Electrophysiology Review

View full text Add to dashboard Cite

Postural tachycardia syndrome (POTS), inappropriate sinus tachycardia (IST) and vasovagal syncope (VVS) are relatively common clinical syndromes that are seen by physicians in several disciplines. They are often not well recognised and are poorly understood by physicians, are associated with significant morbidity and cause significant frustration for both patients and their physicians. The2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia and Vasovagal Syncopeprovides physicians with an introduction to these disorders and initial recommendations on their investigation and treatment. Here we summarise the consensus statement to help physicians in the management of patients with these frequently distressing problems

show abstract

Ivabradine in Combination With Metoprolol Succinate in the Treatment of Inappropriate Sinus Tachycardia

Abstract: Combining ivabradine with metoprolol is an effective and well-tolerated treatment option for IST in patients with refractory to monotherapy.

Cited by 46 publications

References 22 publications

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary

2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope

Management of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia and Vasovagal Syncope

Contact Info

Product

Resources

About